Wednesday, 28 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Acquisition

Dr. Lal Pathlabs Acquisition

Dr. Lal PathLabs' subsidiary, DLPL Dubai, completed the acquisition of an 80% stake in Sunshine Healthcare Limited, Ghana. Sunshine Healthcare is now a step-down subsidiary.

Source

NSE filing, NSE: LALPATHLAB. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Dr. Lal Pathlabs Ltd: key numbers

Share price
₹1,922.30
Market cap
₹32,266 Cr
Revenue (annual)
₹2,763 Cr
Net profit (annual)
₹504.8 Cr
P/E (TTM)
59.5×Sector 52.0×
Promoter holding
52.93%-0.26% QoQ
FII holding
18.73%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Dr. Lal Pathlabs Ltd

All →

Other acquisition announcements

All →